Lin et al. elucidated a novel metastatic mechanism in NSCLC, demonstrating that MDSC-secreted CCL11 promotes tumor progression through ERK/AKT pathway activation and epithelial–mesenchymal transition (EMT) induction. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.